The article on statins in the August edition of The Actuary has blown my mind!
The article on statins in the August edition of The Actuary has blown my mind! I recently retired after a 50-year career as a member of the actuarial profession, latterly as a trustee of a large DB scheme for 10 years, during which time we had to debate our assumptions about future improvements on several occasions.
If the article by the researchers at University of East Anglia is scientifically correct, it changes the expectations about future improvements in longevity at a stroke: if 75% of past improvements can be ascribed to one drug, then what will help in the future?
I have just Googled 'effects of statins on life expectancy', and the top hits relate to sceptical articles from 2015: bit.ly/2yp1prP
If the new article is correct, then the actuarial profession should be making sure that it is getting a wider readership. Of course, that might be tantamount to admitting that the CMI and other actuaries have not noticed what's going on under our noses.
I would hope that the article leads to a considerable number of contributions to your postbag! Please let me know whether others are on the case. Or is it just me getting excited unnecessarily?
10 Sept 2018